COVID-19 Research Paper Volume 13, Issue 7 pp 9225—9242
Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status
Figure 2. Subgroup analysis for systemic and venous thromboembolism. (A) Systemic thromboembolism (n=37); (B) Venous thromboembolism (n=45). * AF: atrial fibrillation. HR: hazard ratio. CI: confidential interval.